PLAN A
Live / Allowed — Notice of allowance issued (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98533200
- Mark type
- Word mark
- Filed
- 03 May 2024
- Published for opposition
- 19 May 2026
- Attorney of record
- SAMANTHA M. QUIMBY
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sexually-transmitted diseases; Diagnostic test reagents for medical purposes; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, injectable contraceptives
Owner
- NEXT Life Sciences Inc., San Luis Obispo, CA, US
- NEXT Life Sciences Inc., San Luis Obispo, CA, US
Board proceedings on this mark
- Ex Parte Appeal No. 98533200 — NEXT Life Sciences Inc., filed 11 Feb 2026 (Terminated)
Prosecution history
- 14 Jul 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 May 2026 — PUBLISHED FOR OPPOSITION
- 13 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Apr 2026 — EXPARTE APPEAL TERMINATED
- 21 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Feb 2026 — EX PARTE APPEAL-INSTITUTED
- 12 Feb 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 12 Feb 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 11 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 13 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 13 Nov 2025 — FINAL REFUSAL E-MAILED
- 13 Nov 2025 — FINAL REFUSAL WRITTEN